{
    "hands_on_practices": [
        {
            "introduction": "The quantitative heart of epitope-paratope recognition lies in the binding affinity, represented by the equilibrium dissociation constant ($K_D$). Understanding how to derive $K_D$ from its underlying kinetic components—the association rate ($k_{on}$) and dissociation rate ($k_{off}$)—is a cornerstone skill for evaluating any antibody-antigen pair. This practice problem  will guide you through calculating $K_D$ from experimental rate constants and applying this value to classify the interaction's strength, a critical step in selecting antibodies for diagnostic assays.",
            "id": "5092969",
            "problem": "A monoclonal immunoglobulin G (IgG) antibody is evaluated for use in a high-specificity molecular immunodiagnostic assay targeting a linear peptide epitope on a soluble viral antigen. To isolate the intrinsic epitope–paratope interaction, a fragment antigen-binding (Fab) version of the antibody is used in a Surface Plasmon Resonance (SPR) experiment at low immobilized ligand density to minimize avidity and rebinding. The reversible binding is modeled as a bimolecular reaction $A + B \\rightleftharpoons AB$ governed by the law of mass action, where $A$ is the epitope-bearing antigen, $B$ is the Fab, and $AB$ is the complex. The measured kinetic rate constants at $T = 298\\ \\mathrm{K}$ are $k_{on} = 2.0 \\times 10^{6}\\ \\mathrm{M}^{-1}\\ \\mathrm{s}^{-1}$ and $k_{off} = 1.0 \\times 10^{-3}\\ \\mathrm{s}^{-1}$.\n\nStarting from the differential rate law for reversible bimolecular association and dissociation under constant total reactant concentrations and invoking equilibrium conditions, derive the equilibrium dissociation constant for this interaction and compute its numerical value for the given kinetic parameters. Then, using widely accepted immunodiagnostic practice, classify the affinity as “high” if $K_{D} \\leq 1.0 \\times 10^{-9}\\ \\mathrm{M}$ and “low” if $K_{D} \\geq 1.0 \\times 10^{-7}\\ \\mathrm{M}$. Round the numerical value of the equilibrium dissociation constant to three significant figures and express it in molar ($\\mathrm{M}$). Report the computed $K_{D}$ as your final numeric answer, and provide the affinity classification in your reasoning.",
            "solution": "The problem statement has been evaluated and is deemed valid. It is scientifically grounded, well-posed, objective, and internally consistent, providing all necessary information to derive and compute the required quantity.\n\nThe problem concerns the reversible bimolecular interaction between a soluble antigen, $A$, and a fragment antigen-binding (Fab) of an antibody, $B$, to form a complex, $AB$. This reaction is represented as:\n$$ A + B \\underset{k_{off}}{\\stackrel{k_{on}}{\\rightleftharpoons}} AB $$\nwhere $k_{on}$ is the association rate constant and $k_{off}$ is the dissociation rate constant.\n\nThe rate of change of the concentration of the complex, $[AB]$, is governed by the law of mass action. The rate of formation of the complex is proportional to the product of the reactant concentrations, $[A]$ and $[B]$, while the rate of its dissociation is proportional to its own concentration, $[AB]$. The net rate of change of $[AB]$ is given by the differential rate law:\n$$ \\frac{d[AB]}{dt} = k_{on}[A][B] - k_{off}[AB] $$\nAt chemical equilibrium, the net rate of change of concentrations of all species is zero. Therefore, we set the rate equation to zero:\n$$ \\frac{d[AB]}{dt} = 0 $$\nThis leads to the condition where the rate of association equals the rate of dissociation:\n$$ k_{on}[A]_{eq}[B]_{eq} = k_{off}[AB]_{eq} $$\nHere, the subscript 'eq' denotes the concentrations of the respective species at equilibrium.\n\nThe equilibrium dissociation constant, $K_D$, is defined as the ratio of the product of the equilibrium concentrations of the reactants to the equilibrium concentration of the product complex. For this reaction, the definition is:\n$$ K_D = \\frac{[A]_{eq}[B]_{eq}}{[AB]_{eq}} $$\nBy rearranging the equilibrium condition derived from the rate law, we can express this ratio in terms of the kinetic rate constants:\n$$ \\frac{[A]_{eq}[B]_{eq}}{[AB]_{eq}} = \\frac{k_{off}}{k_{on}} $$\nTherefore, the equilibrium dissociation constant is the ratio of the dissociation rate constant to the association rate constant:\n$$ K_D = \\frac{k_{off}}{k_{on}} $$\nThe problem provides the following values for the kinetic rate constants measured at $T = 298\\ \\mathrm{K}$:\n- Association rate constant: $k_{on} = 2.0 \\times 10^{6}\\ \\mathrm{M}^{-1}\\ \\mathrm{s}^{-1}$\n- Dissociation rate constant: $k_{off} = 1.0 \\times 10^{-3}\\ \\mathrm{s}^{-1}$\n\nSubstituting these values into the derived expression for $K_D$:\n$$ K_D = \\frac{1.0 \\times 10^{-3}\\ \\mathrm{s}^{-1}}{2.0 \\times 10^{6}\\ \\mathrm{M}^{-1}\\ \\mathrm{s}^{-1}} $$\nThe units $\\mathrm{s}^{-1}$ cancel, leaving units of $\\mathrm{M}$ (molar), which is correct for a dissociation constant.\n$$ K_D = \\frac{1.0}{2.0} \\times 10^{-3-6}\\ \\mathrm{M} $$\n$$ K_D = 0.5 \\times 10^{-9}\\ \\mathrm{M} $$\nTo express this in standard scientific notation and round to three significant figures as requested by the problem statement:\n$$ K_D = 5.00 \\times 10^{-10}\\ \\mathrm{M} $$\n\nThe final step is to classify the affinity based on the provided criteria:\n- \"high\" affinity if $K_D \\leq 1.0 \\times 10^{-9}\\ \\mathrm{M}$\n- \"low\" affinity if $K_D \\geq 1.0 \\times 10^{-7}\\ \\mathrm{M}$\n\nOur computed value is $K_D = 5.00 \\times 10^{-10}\\ \\mathrm{M}$. We compare this to the \"high\" affinity threshold:\n$$ 5.00 \\times 10^{-10}\\ \\mathrm{M} \\leq 1.0 \\times 10^{-9}\\ \\mathrm{M} $$\nThis inequality can be rewritten as:\n$$ 0.500 \\times 10^{-9}\\ \\mathrm{M} \\leq 1.0 \\times 10^{-9}\\ \\mathrm{M} $$\nThis statement is true. The interaction, therefore, falls into the category of \"high\" affinity. A lower $K_D$ value signifies a stronger binding interaction, as a smaller concentration of reactants is required to lead to complex formation.",
            "answer": "$$\\boxed{5.00 \\times 10^{-10}}$$"
        },
        {
            "introduction": "Beyond numerical affinity, the physical structure of an epitope is paramount for recognition. This is especially true for conformational epitopes, which depend on the antigen's native three-dimensional fold. The following exercise  challenges you to predict how an antibody specific for a conformational epitope will behave in two common immunoassays with vastly different sample preparation methods, forcing you to connect the molecular-level structure of the epitope to macro-level experimental outcomes.",
            "id": "5092930",
            "problem": "A monoclonal immunoglobulin G subclass 1 (IgG1) antibody is raised against antigen $X$, a disulfide-bonded glycoprotein whose epitope requires the native tertiary fold and intact disulfide topology. The antibody has high affinity for the native antigen with dissociation constant $K_D$ in the low nanomolar range under physiological buffer. You perform the following two assays:\n\n- Western blot: The sample is first subjected to Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE) under reducing conditions with sodium dodecyl sulfate (SDS) and dithiothreitol (DTT), then proteins are transferred to a polyvinylidene fluoride (PVDF) membrane and probed with the antibody.\n- Sandwich Enzyme-Linked Immunosorbent Assay (ELISA): A noncompeting capture antibody immobilized on polystyrene wells binds antigen $X$ from native lysate prepared in non-denaturing buffer without SDS, without reducing agents, and at neutral pH; after capture, the monoclonal IgG1 antibody above is used as the detection antibody.\n\nUsing the following first-principles considerations, predict the binding outcome of the conformational-epitope antibody in each assay:\n\n- Conformational epitopes require a native three-dimensional arrangement of noncontiguous residues and, when that arrangement is disrupted by denaturation (including SDS binding to the polypeptide backbone and reduction of disulfide bonds), the epitope is lost.\n- In SDS-PAGE, SDS binds at roughly one detergent molecule per two amino acid residues, imposing a large negative charge and linearizing the polypeptide chain, while reducing agents break covalent disulfide constraints, both of which drive unfolding; proteins transferred to membranes largely remain in this denatured ensemble without efficient refolding.\n- In sandwich ELISA under native capture, the antigen is bound out of solution in its folded ensemble; the fraction of native antigen $f_N$ remains near unity in the absence of denaturants, so the epitope topology is preserved.\n- Antibody occupancy on the target epitope scales with the concentration of native epitope according to the law of mass action; if the concentration of native antigen $[Ag_N]$ approaches zero, the fraction bound approaches zero even for small $K_D$.\n\nWhich statement best describes the expected binding pattern of the conformational-epitope antibody under these stated conditions?\n\nA. The antibody will bind strongly in Western blot but fail to bind in ELISA because adsorption to plastic disrupts the conformational epitope, whereas transfer to PVDF restores native folding.\n\nB. The antibody will fail to bind in both assays because SDS denaturation in Western blot destroys the epitope and capture in ELISA also fully denatures the antigen to a linearized state.\n\nC. The antibody will not bind in Western blot but will bind in sandwich ELISA, because SDS and reduction disrupt the epitope in the blot, while native capture in ELISA preserves the epitope.\n\nD. The antibody will bind robustly in both assays because high affinity (low $K_D$) ensures recognition irrespective of antigen conformation or denaturation state.",
            "solution": "The user has provided a problem in the domain of molecular immunodiagnostics, requiring the prediction of antibody binding in two different standard immunoassays: a Western blot and a sandwich ELISA. The problem statement's validity must be assessed before proceeding.\n\n### Step 1: Extract Givens\n\n-   **Antibody**: A monoclonal immunoglobulin G subclass 1 ($IgG1$) antibody.\n-   **Antigen ($X$)**: A disulfide-bonded glycoprotein.\n-   **Epitope Type**: A conformational epitope, which explicitly requires the native tertiary fold and intact disulfide topology of antigen $X$.\n-   **Binding Affinity**: The antibody has high affinity for the native antigen, with a dissociation constant, $K_D$, in the low nanomolar range.\n-   **Assay 1 (Western blot) Conditions**:\n    -   Sample preparation: Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis ($SDS-PAGE$).\n    -   Chemical environment: Reducing conditions, with sodium dodecyl sulfate ($SDS$) and dithiothreitol ($DTT$).\n    -   Detection: Proteins are transferred to a polyvinylidene fluoride ($PVDF$) membrane and probed with the antibody.\n-   **Assay 2 (Sandwich ELISA) Conditions**:\n    -   Capture: A noncompeting capture antibody immobilized on a plate binds antigen $X$ from a native lysate.\n    -   Lysate preparation: Non-denaturing buffer, without $SDS$, without reducing agents, at neutral pH.\n    -   Detection: The specified monoclonal $IgG1$ antibody is used as the detection antibody.\n-   **Governing Principles (provided)**:\n    1.  Conformational epitopes are destroyed by denaturation (e.g., by $SDS$) and reduction of disulfide bonds.\n    2.  $SDS-PAGE$ under reducing conditions linearizes and denatures proteins. This denatured state is largely preserved after transfer to a membrane.\n    3.  Sandwich ELISA under the specified native conditions preserves the antigen's folded state, maintaining the epitope's topology ($f_N \\approx 1$).\n    4.  Antibody binding requires a non-zero concentration of the correctly-folded epitope ($[Ag_N]$). If $[Ag_N] \\to 0$, binding approaches $0$.\n\n### Step 2: Validate Using Extracted Givens\n\n-   **Scientific Groundedness**: The problem is scientifically sound. It accurately describes the properties of a conformational epitope and the biochemical effects of the reagents and procedures used in Western blotting ($SDS$, $DTT$) and native sandwich ELISA. These are fundamental, well-established principles in biochemistry and immunology.\n-   **Well-Posed**: The problem is well-posed. It provides a clear set of initial conditions (antibody type, epitope nature, assay conditions) and a set of established principles. It asks for a logical deduction of the outcome, for which a unique solution exists.\n-   **Objectivity**: The problem is stated in objective, technical language. There are no subjective or ambiguous terms.\n-   **Completeness and Consistency**: The problem is self-contained and internally consistent. The properties of the antibody (recognizing a conformational epitope) are directly relevant to the conditions of the assays (denaturing vs. native). The provided \"first-principles\" reinforce, rather than contradict, the standard understanding of these techniques.\n-   **Realism and Feasibility**: The scenario is highly realistic. Characterizing an antibody's performance in different immunoassays, particularly its sensitivity to antigen denaturation, is a routine and critical task in antibody development and diagnostics.\n-   **Other Flaws**: The problem is not trivial, ill-posed, or metaphorical. It is a straightforward test of applying core biochemical principles to a practical scenario.\n\n### Step 3: Verdict and Action\n\nThe problem statement is **valid**. It is scientifically sound, well-posed, and complete. A solution can be derived from the provided information and principles.\n\n### Derivation of Solution\n\nThe solution hinges on the nature of the antibody's epitope and the state of the antigen in each assay.\n\n1.  **Epitope Definition**: The antibody recognizes a *conformational epitope*. By definition, this means the antibody binds to a specific three-dimensional shape on the antigen's surface. This shape is a product of the protein's tertiary structure (its fold) and, in this case, is stabilized by covalent disulfide bonds. If this structure is disrupted, the epitope ceases to exist.\n\n2.  **Analysis of the Western Blot Assay**:\n    -   The antigen sample is treated with $SDS$ and $DTT$ and heated before electrophoresis.\n    -   $SDS$ is a powerful anionic detergent. As stated in the principles, it binds to the polypeptide chain (at a ratio of approximately one $SDS$ molecule per two amino acids), imparting a uniform negative charge and disrupting virtually all non-covalent interactions that stabilize the native protein fold. This linearizes the protein.\n    -   $DTT$ is a reducing agent. Its function is to break the covalent disulfide bonds (-S-S-) by reducing them to sulfhydryl groups (-SH SH-). This eliminates the \"intact disulfide topology\" required for the epitope.\n    -   The combined action of $SDS$ and $DTT$ completely denatures the glycoprotein, destroying its tertiary structure and breaking key covalent constraints.\n    -   The conformational epitope is therefore destroyed. The concentration of the natively folded antigen, $[Ag_N]$, is effectively $0$.\n    -   According to the fourth principle provided, because $[Ag_N] \\to 0$, the antibody binding will also approach $0$. Therefore, the antibody is not expected to produce a signal in the Western blot.\n\n3.  **Analysis of the Sandwich ELISA Assay**:\n    -   The antigen is prepared in a \"native lysate\" using a \"non-denaturing buffer\" that lacks $SDS$ and reducing agents.\n    -   These conditions are specifically designed to preserve the native, folded structure of proteins. The third principle confirms this, stating the fraction of native antigen, $f_N$, is near unity ($1$) and the epitope topology is preserved.\n    -   The antigen is first \"captured\" by another antibody. In a sandwich assay format, this capture step is designed to immobilize the antigen while maintaining its native conformation.\n    -   The monoclonal antibody in question is then used for detection. Since the antigen is presented in its native state, the conformational epitope is intact and available for binding.\n    -   The problem states the antibody has a high affinity ($K_D$ in the low nanomolar range). This ensures that, given the presence of the correct epitope, strong binding will occur.\n    -   Therefore, the antibody is expected to bind robustly to the captured antigen and produce a strong signal in the sandwich ELISA.\n\n**Conclusion**: The antibody will not bind in the reducing Western blot but will bind in the native sandwich ELISA.\n\n### Evaluation of Options\n\n-   **A. The antibody will bind strongly in Western blot but fail to bind in ELISA because adsorption to plastic disrupts the conformational epitope, whereas transfer to PVDF restores native folding.**\n    This statement is incorrect. The prediction for both assays is wrong. Binding will fail in Western blot due to denaturation. Binding will succeed in the native sandwich ELISA. The provided reasoning is also flawed: transfer to a $PVDF$ membrane from an $SDS$ gel does not typically restore native folding, and in a sandwich ELISA, the capture antibody serves to stabilize the antigen, not denature it. **Incorrect**.\n\n-   **B. The antibody will fail to bind in both assays because SDS denaturation in Western blot destroys the epitope and capture in ELISA also fully denatures the antigen to a linearized state.**\n    This statement is partially correct about the Western blot outcome but incorrect about the ELISA outcome. The conditions for the ELISA are explicitly native and non-denaturing, preserving the epitope. The claim that capture in ELISA denatures the antigen is contrary to the problem statement and standard practice for this assay type. **Incorrect**.\n\n-   **C. The antibody will not bind in Western blot but will bind in sandwich ELISA, because SDS and reduction disrupt the epitope in the blot, while native capture in ELISA preserves the epitope.**\n    This statement accurately predicts the outcome for both assays based on the correct underlying principles. The Western blot fails due to denaturation and reduction by $SDS$ and $DTT$. The sandwich ELISA succeeds because the native conditions preserve the conformational epitope. This aligns perfectly with our derivation. **Correct**.\n\n-   **D. The antibody will bind robustly in both assays because high affinity (low $K_D$) ensures recognition irrespective of antigen conformation or denaturation state.**\n    This statement is incorrect. It fundamentally misunderstands the concept of affinity. High affinity ($K_D$) is a measure of the binding strength to the *correctly formed epitope*. It does not grant the antibody a magical ability to bind to a denatured protein where the epitope no longer exists. Affinity is irrelevant if the binding site is destroyed. **Incorrect**.",
            "answer": "$$\\boxed{C}$$"
        },
        {
            "introduction": "Antibody affinity is not a fixed property but is refined over the course of an immune response through a process called affinity maturation. This biological optimization primarily involves the selection of B cells producing antibodies with slower dissociation rates ($k_{off}$), leading to more stable antibody-antigen complexes. This final exercise  provides a practical, hands-on simulation of how biophysical data from techniques like Surface Plasmon Resonance (SPR) can be analyzed to track this decrease in $k_{off}$ over time, offering a quantitative window into this fundamental process of adaptive immunity.",
            "id": "5092994",
            "problem": "An immunization study evaluates whether B cell affinity maturation toward a fixed epitope has occurred by quantifying the dissociation rate constant of antibody-epitope complexes across time. Using Surface Plasmon Resonance (SPR) under conditions designed to minimize rebinding and mass-transport limitation (low ligand density, high flow), dissociation phases were recorded for antibodies sampled at three time points post-immunization: day $7$, day $14$, and day $28$. Assume a single class of independent binding sites and one-to-one epitope-paratope interactions. The measured SPR response is proportional to the concentration of bound complex: if $[AB](t)$ is the surface-bound complex concentration, then $R(t) = \\kappa [AB](t)$ for a constant proportionality factor $\\kappa$ (Response Units (RU) per concentration unit). Dissociation of the complex follows a first-order rate law for the elementary reaction $AB \\to A + B$, so that the rate is proportional to the instantaneous complex concentration.\n\nYou are provided the dissociation-phase responses at times $t = 0$ s, $t = 30$ s, $t = 60$ s, and $t = 120$ s for each day:\n\n- Day $7$: $R(0) = 150.0$ RU, $R(30) = 111.1$ RU, $R(60) = 82.3$ RU, $R(120) = 45.2$ RU.\n- Day $14$: $R(0) = 110.0$ RU, $R(30) = 94.7$ RU, $R(60) = 81.5$ RU, $R(120) = 60.4$ RU.\n- Day $28$: $R(0) = 90.0$ RU, $R(30) = 84.8$ RU, $R(60) = 79.8$ RU, $R(120) = 70.8$ RU.\n\nStarting only from the first-order rate law for dissociation of a single species and the proportionality between $R(t)$ and $[AB](t)$, derive an expression for the dissociation rate constant $k_{\\text{off}}$ in terms of $R(0)$, $R(t)$, and $t$, and then compute $k_{\\text{off}}$ for day $7$ and day $28$ using the measurements at $t = 0$ s and $t = 120$ s. Define the fold-change in dissociation rate between day $7$ and day $28$ as $F = \\dfrac{k_{\\text{off, day }7}}{k_{\\text{off, day }28}}$. Compute $F$ and round your final value of $F$ to three significant figures. Express $F$ as a pure number (no units).",
            "solution": "The problem statement has been critically validated and is deemed valid. It is scientifically grounded in the principles of chemical kinetics and immunology, well-posed with sufficient and consistent data, and objectively stated. The experimental context of using Surface Plasmon Resonance (SPR) to study affinity maturation is a standard and well-established method in molecular biology and immunodiagnostics. The problem will now be solved as stated.\n\nThe first step is to derive the expression for the dissociation rate constant, $k_{\\text{off}}$, from the given first-order rate law.\nThe problem states that the dissociation of the antibody-epitope complex, $AB$, into free antibody, $A$, and free epitope, $B$, is a first-order elementary reaction: $AB \\xrightarrow{k_{\\text{off}}} A + B$.\nThe rate of this reaction is proportional to the concentration of the complex, $[AB]$. This is expressed by the differential equation:\n$$\n\\frac{d[AB](t)}{dt} = -k_{\\text{off}} [AB](t)\n$$\nwhere $t$ is time and $k_{\\text{off}}$ is the dissociation rate constant. This is a first-order separable ordinary differential equation. We can solve it by separating variables and integrating:\n$$\n\\frac{d[AB](t)}{[AB](t)} = -k_{\\text{off}} dt\n$$\nIntegrating both sides from time $t=0$ to a general time $t$:\n$$\n\\int_{[AB](0)}^{[AB](t)} \\frac{d[AB]'}{[AB]'} = \\int_{0}^{t} -k_{\\text{off}} dt'\n$$\nThe integration yields:\n$$\n\\ln([AB](t)) - \\ln([AB](0)) = -k_{\\text{off}} (t - 0)\n$$\nUsing the properties of logarithms, this becomes:\n$$\n\\ln\\left(\\frac{[AB](t)}{[AB](0)}\\right) = -k_{\\text{off}} t\n$$\nExponentiating both sides gives the time evolution of the complex concentration:\n$$\n[AB](t) = [AB](0) \\exp(-k_{\\text{off}} t)\n$$\nThe problem states that the SPR response, $R(t)$, is directly proportional to the concentration of the surface-bound complex, $[AB](t)$, via a constant factor $\\kappa$: $R(t) = \\kappa [AB](t)$.\nSubstituting this relationship into the kinetic equation:\n$$\n\\frac{R(t)}{\\kappa} = \\frac{R(0)}{\\kappa} \\exp(-k_{\\text{off}} t)\n$$\nThe proportionality constant $\\kappa$ cancels from both sides, yielding an equation for the SPR response as a function of time:\n$$\nR(t) = R(0) \\exp(-k_{\\text{off}} t)\n$$\nTo find an expression for $k_{\\text{off}}$, we rearrange this equation. First, divide by $R(0)$:\n$$\n\\frac{R(t)}{R(0)} = \\exp(-k_{\\text{off}} t)\n$$\nNext, take the natural logarithm of both sides:\n$$\n\\ln\\left(\\frac{R(t)}{R(0)}\\right) = -k_{\\text{off}} t\n$$\nFinally, solving for $k_{\\text{off}}$ gives the desired expression:\n$$\nk_{\\text{off}} = -\\frac{1}{t} \\ln\\left(\\frac{R(t)}{R(0)}\\right)\n$$\nThis expression can also be written as:\n$$\nk_{\\text{off}} = \\frac{1}{t} \\ln\\left(\\frac{R(0)}{R(t)}\\right)\n$$\nThis is the derived expression for the dissociation rate constant in terms of the initial response $R(0)$, the response at time $t$, $R(t)$, and the time $t$.\n\nThe next step is to compute $k_{\\text{off}}$ for day $7$ and day $28$ using the provided data at $t = 120$ s.\n\nFor day $7$, the data are $R(0) = 150.0$ RU and $R(120) = 45.2$ RU at $t = 120$ s.\n$$\nk_{\\text{off, day }7} = \\frac{1}{120 \\text{ s}} \\ln\\left(\\frac{150.0}{45.2}\\right)\n$$\nFor day $28$, the data are $R(0) = 90.0$ RU and $R(120) = 70.8$ RU at $t = 120$ s.\n$$\nk_{\\text{off, day }28} = \\frac{1}{120 \\text{ s}} \\ln\\left(\\frac{90.0}{70.8}\\right)\n$$\n\nThe final step is to compute the fold-change, $F$, defined as the ratio of the two rate constants:\n$$\nF = \\frac{k_{\\text{off, day }7}}{k_{\\text{off, day }28}}\n$$\nSubstituting the expressions for the rate constants:\n$$\nF = \\frac{\\frac{1}{120 \\text{ s}} \\ln\\left(\\frac{150.0}{45.2}\\right)}{\\frac{1}{120 \\text{ s}} \\ln\\left(\\frac{90.0}{70.8}\\right)}\n$$\nThe term $\\frac{1}{120 \\text{ s}}$ cancels out, simplifying the expression for $F$:\n$$\nF = \\frac{\\ln\\left(\\frac{150.0}{45.2}\\right)}{\\ln\\left(\\frac{90.0}{70.8}\\right)}\n$$\nNow we compute the numerical value for $F$.\nFirst, calculate the ratios:\n$$\n\\frac{150.0}{45.2} \\approx 3.318584\n$$\n$$\n\\frac{90.0}{70.8} \\approx 1.271186\n$$\nNext, take the natural logarithms:\n$$\n\\ln(3.318584) \\approx 1.19950\n$$\n$$\n\\ln(1.271186) \\approx 0.24000\n$$\nFinally, calculate the ratio of the logarithms:\n$$\nF = \\frac{1.19950}{0.24000} \\approx 4.997916...\n$$\nThe problem requires the final value of $F$ to be rounded to three significant figures.\n$$\nF \\approx 5.00\n$$\nThe decrease in the dissociation rate constant from day $7$ to day $28$ reflects affinity maturation, where the immune system selects for B cells producing antibodies that bind more tightly (dissociate more slowly) to the target epitope. A fold-change of approximately $5$ indicates a significant increase in the stability of the antibody-epitope complex.",
            "answer": "$$\\boxed{5.00}$$"
        }
    ]
}